| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,108 | 2,449 | 4,011 | 4,269 | | Cost of Revenue | 546 | 493 | 461 | 479 | | | Gross Profit | 2,562 | 1,956 | 3,550 | 3,790 | | | Operating Expenses | | Research Development | 9,349 | 11,401 | 10,849 | 11,949 | | Selling General and Administrative | 5,206 | 5,357 | 6,016 | 5,702 | | Non Recurring |
-
| 1,506 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (11,993) | (16,308) | (13,315) | (13,861) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 33 | (248) | (49) | (781) | | Earnings Before Interest And Taxes | (11,960) | (16,556) | (13,364) | (14,642) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (11,960) | (16,556) | (13,364) | (14,642) | | Income Tax Expense | (294) | (241) | (438) | (693) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (11,666) | (16,315) | (12,926) | (13,949) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (11,666) | (16,315) | (12,926) | (13,949) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($11,666) | ($16,315) | ($12,926) | ($13,949) |
|
0.03% Nasdaq 0.00%
Income Statement
